EMEA-002421-PIP01-18

Key facts

Active substance
  • levodopa
  • carbidopa monohydrate
  • entacapone
Therapeutic area
Neurology
Decision number
P/0011/2019
PIP number
EMEA-002421-PIP01-18
Pharmaceutical form(s)
Intestinal gel
Route(s) of administration
Intestinal use
Contact for public enquiries
LobSor Pharmaceuticals AB

E-mail: info@lobsor.com
Tel. +46 7222 24408

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating